Skip to content

Minimal Invasive Volar Plating Versus Cast Immobilization for Treatment of Stable Non-displaced Distal Radial Fractures.

Minimal Invasive Volar Plating Versus Cast Immobilization for Treatment of Stable Non-displaced Distal Radial Fractures.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05015556
Enrollment
90
Registered
2021-08-20
Start date
2022-09-01
Completion date
2023-12-31
Last updated
2022-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radius Fracture Distal

Keywords

Minimal invasive, Osteosynthesis, Conservative treatment, Cost effectiveness

Brief summary

Nondisplaced distal radial fractures are nowadays treated by plaster cast immobilization. In this study, the investigators challenge this classical standard treatment with a surgical solution: minimal invasive volar plating with pronatus quadratus sparing approach. Potential benefits of this surgical treatment are higher cost effectiveness, economical benefit, earlier recuperation of professional and recreational activities, earlier functional recuperation by faster clinical recovery (range of motion, grip strength) and decreased risk of secondary fracture displacement. Potential drawbacks are surgical risks and complications.

Detailed description

Randomized controlled trial Number still to be determined by power analysis on economical outcome measurement Similar study number = 90 Randomization by computer. RZ Tienen, Dr Goorens Level 4 hand surgeon Inclusion criteria: * Stable distal radial fractures (volar tilt \<10° dorsal tilt, \<2mm impaction, \<2mm articular depression) * 18 - 65 years, professional active Exclusion criteria: * associated lesions, open fractures, unstable, displaced fractures * neurological disorder affecting the upper limb, history of wrist lesion involving the same wrist, dementia, substance abuse, severe psychiatric disorder and previous injured contralateral wrist Treatment 1. Cast treatment: 6 weeks with 1 plaster exchange of after 2 weeks 2. Minimal invasive plating: no cast Followup 2 weeks, 6 weeks, 3 months, 6 months, 1 year Primary PROM: * Cost effectiveness: QALY SF-36 * Direct costs: surgery, hospitalisation, follow-up consultations, imaging, medication, wound care, nurse cost, physiotherapy cost * Indirect costs: loss of productivity (SF-HLQ) * Health insurances costs * Confounding factors * Independent vs servant * Insurance? * Work type? * Age, sex, dominance * Work absence, professional recuperation * Recreational sport resumption Secondary PROM * ROM (F/E/RD/UD/P/S) * Grip strength (Jamar) * Pain (VAS) * DASH scare, PRWE score * Satisfaction (VAS), would you do it again? * RX ulna variance, radial tilt * complications

Interventions

PROCEDUREMinimal invasive volar plating

Muscle sparing osteosynthesis, no casting postoperatively

Sponsors

Goorens Chul Ki
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Blinding of results by computer of the outcome results. Blinding of the patients or the care provider is not possible due to the obvious differences.

Eligibility

Sex/Gender
ALL
Age
16 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Stable distal radial fractures (volar tilt \<10° dorsal tilt, \<2mm impaction, \<2mm articular depression) * 18 - 65 years, professional active

Exclusion criteria

* associated lesions, open fractures, unstable, displaced fractures * neurological disorder affecting the upper limb, history of wrist lesion involving the same wrist, dementia, substance abuse, severe psychiatric disorder and previous injured contralateral wrist

Design outcomes

Primary

MeasureTime frameDescription
QALY1 yearUsing the Short Form 36 (SF-36) assessment - cost effectiveness (The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.)
Costs1 yearDirect, indirect, health insurances

Secondary

MeasureTime frameDescription
VAS1 yearPain using the VAS (0-10)
Wrist ROM1 yearRange of motion (flexion, extension, radial deviation, ulnar deviation, pronation, supination)
PRWE1 yearPatient rated wrist evaluation (0-100, lower score, means better outcome)
DASH1 yearDisabilities of the arm, shoulder and hand (0-100, lower score means better outcome)
Grip Strength1 yearUsing the Jamar grip dynamometer

Countries

Belgium

Contacts

Primary Contactchul ki goorens, MD
cgoorens@msn.com0032478907124

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026